FDA Inspection 1087127 — Jiangsu NHWA Pharmaceutical Co., Ltd.
The FDA completed an inspection of Jiangsu NHWA Pharmaceutical Co., Ltd. on Apr 5, 2019 in Xuzhou. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 5, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xuzhou (China)